QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbols |
Name of each exchange on which registered | ||
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant |
||||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
| ☒ | Smaller reporting company | |||||
| Emerging growth company | ||||||
Page |
||||
1 |
||||
1 |
||||
2 |
||||
3 |
||||
4 |
||||
5 |
||||
16 |
||||
19 |
||||
19 |
||||
19 |
||||
19 |
||||
20 |
||||
20 |
||||
20 |
||||
20 |
||||
20 |
||||
21 |
||||
September 30, 2021 |
December 31, 2020 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
— | |||||||
Total Current Assets |
||||||||
Deferred offering costs |
— | |||||||
Investment s held in Trust Account |
— | |||||||
TOTAL ASSETS |
$ |
$ |
||||||
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | $ | ||||||
Accrued offering costs |
— | |||||||
Promissory note – related party |
— | |||||||
Total Current Liabilities |
||||||||
Warrant liability |
— | |||||||
Deferred underwriting fee payable |
— | |||||||
Total Liabilities |
||||||||
Commitments and Contingencies |
||||||||
Class A common stock subject to possible redemption, $ |
— | |||||||
Stockholders’ (Deficit) Equity |
||||||||
Preferred stock, $ |
||||||||
Class B common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total Stockholders’ (Deficit) Equity |
( |
) |
||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |
$ |
$ |
||||||
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
|||||||
Formation and operational costs |
$ | $ | ||||||
Loss from operations |
( |
) |
( |
) | ||||
Other income: |
||||||||
Change in fair value of warrant liabilities |
||||||||
Transaction costs incurred in connection with warrant liability |
— | ( |
) | |||||
Interest earned on investments held in Trust Account |
||||||||
Total other income, net |
||||||||
Net income (loss) |
$ |
$ |
( |
) | ||||
Weighted average shares outstanding, Class A redeemable common stock |
||||||||
Basic and diluted net income (loss) per share, Class A redeemable common stock |
$ |
$ |
( |
) | ||||
Weighted average shares outstanding, Class B non-redeemable common stock |
||||||||
Basic and diluted net income (loss) per share, Class B non-redeemable common stock |
$ |
$ |
( |
) | ||||
Class A Common Stock |
Class B Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Equity (Deficit) |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
| Balance — January 1, 2021 |
— |
$ |
— |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||
| Cash paid in excess of fair value for Private Placement Warrants |
— | — | — | — | — | |||||||||||||||||||||||
| Accretion for Class A common stock subject to redemption amount |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
| Net income |
— | — | — | — | — | |||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – March 31, 2021 |
— |
$ |
— |
$ |
$ | — | $ |
( |
) |
$ |
( |
) | ||||||||||||||||
| Net loss |
— | — |
— | — | — | ( |
) | ( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – June 30, 2021 |
— |
$ |
— |
$ |
$ | — | $ |
( |
) |
$ |
( |
) | ||||||||||||||||
| Net income |
||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – September 30, 2021 |
— |
$ |
— |
$ |
$ | — | $ |
( |
) |
$ |
( |
) | ||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Cash Flows from Operating Activities: |
||||
| Net loss |
$ | ( |
) | |
| Adjustments to reconcile net loss to net cash used in operating activities: |
||||
| Change in fair value of warrant liabilities |
( |
) | ||
| Transaction costs incurred in connection with warrant liability |
||||
| Interest earned on investments held in Trust Account |
( |
) | ||
| Changes in operating assets and liabilities: |
||||
| Prepaid expenses |
( |
) | ||
| Accrued expenses |
||||
| |
|
|||
| Net cash used in operating activities |
( |
) | ||
| |
|
|||
| Cash Flows from Investing Activities: |
||||
| Investment of cash in Trust Account |
( |
) | ||
| |
|
|||
| Net cash used in investing activities |
( |
) | ||
| |
|
|||
| Cash Flows from Financing Activities |
||||
| Proceeds from sale of Public Offering, net of underwriting discounts paid |
||||
| Underwriting discounts paid |
|
|
( |
) |
| Proceeds from sale of Private Placements Warrants |
||||
| Proceeds from promissory note—related party |
||||
| Repayment of promissory note—related party |
( |
) | ||
| Payment of offering costs |
( |
) | ||
| |
|
|||
| Net cash provided by financing activities |
$ |
|||
| |
|
|||
| Net Change in Cash |
||||
| Cash – Beginning of period |
||||
| Cash – End of period |
$ |
|||
| |
|
|||
| Non-Cash investing and financing activities: |
||||
| Deferred underwriting fee payable |
$ | |||
| |
|
Balance Sheet as of January 14, 2021 (audited) |
As Previously Reported |
Adjustment |
As Revised |
|||||||||
| Class A common stock subject to possible redemption |
$ | $ | $ | |||||||||
| Class A common stock |
$ | $ | ( |
) | $ | |||||||
| Additional paid-in capital |
$ | $ | ( |
) | $ | |||||||
| Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Total Stockholders’ Equity (Deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
| Gross proceeds |
$ | |||
| Less: |
||||
| Proceeds allocated to Public Warrants |
$ | ( |
) | |
| Class A common stock issuance costs |
( |
) | ||
| Plus: |
||||
| Accretion of carrying value to redemption value |
$ | |||
| |
|
|||
| Class A common stock subject to possible redemption |
$ | |||
| |
|
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
| Basic and diluted net income per common stock |
||||||||||||||||
| Numerator: |
||||||||||||||||
| Allocation of net income (loss), as adjusted |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||
| Denominator: |
||||||||||||||||
| Basic and diluted weighted average shares outstanding |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Basic and diluted net income (loss) per common stock |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||
| • | in whole and not in part; |
| • | at a price of $ |
| • | upon a minimum of |
| • | if, and only if, the closing price of the Class A common stock equals or exceeds $ 30 -trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. |
| • | in whole and not in part; |
| • | at $ |
| • | if, and only if, the closing price of our Class A common stock equals or exceeds $ |
| Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
| Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
| Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. | |
| Description |
Level |
September 30, 2021 |
||||||
| Assets: |
||||||||
| Investments held in Trust Account – U.S. Treasury Securities Money Market Fund |
1 | $ | ||||||
| Liabilities | Level | Fair Value | ||||||||
| September 30, 2021 |
Warrant Liability – Public Warrants |
1 | ||||||||
| September 30, 2021 |
Warrant Liability – Private Placement Warrants |
2 |
||||||||
Private Placement |
Public |
Warrant Liabilities |
||||||||||
| Fair value as of January 1, 2021 |
$ | $ | $ | |||||||||
| Initial measurement on January 14, 2021 |
||||||||||||
| Change in fair value |
( |
) | ( |
) | ( |
) | ||||||
| Transfer to level 1 |
( |
) | ( |
) | ||||||||
| |
|
|
|
|
|
|||||||
| Fair value as of March 31, 2021 |
$ | $ | $ | |||||||||
| Change in fair value |
||||||||||||
| |
|
|
|
|
|
|||||||
| Fair value as of June 30, 2021 |
$ | $ | $ | |||||||||
| Change in fair value |
( |
) | ( |
) | ||||||||
| Transfer to level 2 |
|
|
( |
) |
|
|
|
|
|
|
( |
) |
| |
|
|
|
|
|
|||||||
| Fair value as of September 30, 2021 |
$ | $ | $ | |||||||||
| |
|
|
|
|
|
|||||||
| 101.INS* | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document | |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS) | |
| * | Filed herewith. |
| ** | Furnished. |
| (1) | Previously filed as an exhibit to our Current Report on Form 8-K filed on January 15, 2021 and incorporated by reference herein. |
| (2) | Previously filed as an exhibit to our Form S-1 filed on December 22, 2020 and incorporated by reference herein. |
ATHLON ACQUISITION CORP. | ||||||
| Date: November 2, 2021 | By: | /s/ Chris Hickey | ||||
| Name: | Chris Hickey | |||||
| Title: | Chief Executive Officer and Director | |||||
| (Principal Executive Officer) | ||||||
| By: | /s/ David Poltack | |||||
| Name: | David Poltack | |||||
| Title: | Chief Financial Officer (Principal Accounting and Financial Officer) | |||||